Together Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Together Pharma has a total shareholder equity of ₪47.5M and total debt of ₪46.6M, which brings its debt-to-equity ratio to 98.2%. Its total assets and total liabilities are ₪154.3M and ₪106.8M respectively. Together Pharma's EBIT is ₪23.7M making its interest coverage ratio 1.5. It has cash and short-term investments of ₪7.6M.
Key information
98.2%
Debt to equity ratio
₪46.62m
Debt
| Interest coverage ratio | 1.5x |
| Cash | ₪7.58m |
| Equity | ₪47.50m |
| Total liabilities | ₪106.82m |
| Total assets | ₪154.32m |
Recent financial health updates
Is Together Pharma (TLV:TGTR) A Risky Investment?
Sep 13
Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet
Oct 09Is Together Pharma (TLV:TGTR) Using Debt Sensibly?
May 27Is Together Pharma (TLV:TGTR) Using Too Much Debt?
Jan 05Is Together Pharma (TLV:TGTR) Using Too Much Debt?
Sep 03Recent updates
Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues
Nov 04Is Together Pharma (TLV:TGTR) A Risky Investment?
Sep 13Investors Holding Back On Together Pharma Ltd (TLV:TGTR)
Aug 02Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital
May 31Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce
Apr 04A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price
Dec 28Returns At Together Pharma (TLV:TGTR) Are On The Way Up
Nov 13Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet
Oct 09Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors
Sep 03Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors
Sep 03Is Together Pharma (TLV:TGTR) Using Debt Sensibly?
May 27Is Together Pharma (TLV:TGTR) Using Too Much Debt?
Jan 05Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital
Oct 28Is Together Pharma (TLV:TGTR) Using Too Much Debt?
Sep 03Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger
Jul 29Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden
Apr 08Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?
Dec 24Financial Position Analysis
Short Term Liabilities: TGTR's short term assets (₪89.3M) exceed its short term liabilities (₪71.7M).
Long Term Liabilities: TGTR's short term assets (₪89.3M) exceed its long term liabilities (₪35.2M).
Debt to Equity History and Analysis
Debt Level: TGTR's net debt to equity ratio (82.2%) is considered high.
Reducing Debt: TGTR had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable TGTR has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: TGTR is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 27.8% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:02 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Together Pharma Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|